Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity
Purpose. This study aims to evaluate the regression of retinopathy of prematurity (ROP) after one intravitreal injection of bevacizumab and the factors that influenced it. Methods. This retrospective case series was carried out at the “Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoc...
Saved in:
Main Authors: | Simona Delia Nicoară, Constanța Nascutzy, Cristina Cristian, Iulian Irimescu, Anne Claudia Ștefănuț, Gabriela Zaharie, Tudor Drugan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2015/102582 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage
by: Yu Xu, et al.
Published: (2016-01-01) -
Aggressive Posterior Retinopathy of Prematurity (APROP): LASER as the Primary Modality of Treatment
by: Shilpi H Narnaware, et al.
Published: (2021-07-01) -
Comparison of reactivation between ranibizumab and bevacizumab in aggressive retinopathy of prematurity: A retrospective case series
by: Anil Babanrao Gangwe, et al.
Published: (2025-01-01) -
Outcome and Prognostic Factors for Traumatic Endophthalmitis over a 5-Year Period
by: Simona Delia Nicoară, et al.
Published: (2014-01-01) -
Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
by: J. Fernando Arevalo, et al.
Published: (2011-01-01)